Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative dobutamine infusion in DIEP flap breast reconstruction
NL-OMON26226Active, not recruiting
- Sponsor
- Orbis Medisch Centrum
- Start
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dobutamine in breast cancer (3 arms), sponsored by Orbis Medisch Centrum. Primary endpoint: Increase in microcirculatory blood flow. Started Nov 2013; status: active, not recruiting.
02
Drugs
dobutamine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NL-OMON26226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26226.